Steward Partners Investment Advisory’s Voyager Therapeutics VYGR Stock Holding History

Steward Partners Investment Advisory’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-400	Closed	-$1.54K	–	4876
2026 Q1	$1.54K	Hold	400	–	–	﹤0.01%	4117
2025 Q4	$1.57K	Hold	400	–	–	﹤0.01%	4013
2025 Q3	$1.87K	Hold	400	–	–	﹤0.01%	3940
2025 Q2	$1.24K	Hold	400	–	–	﹤0.01%	3825
2025 Q1	$1.35K	Hold	400	–	–	﹤0.01%	3720
2024 Q4	$2.27K	Hold	400	–	–	﹤0.01%	3605
2024 Q3	$2.34K	Hold	400	–	–	﹤0.01%	3412
2024 Q2	$3.16K	Hold	400	–	–	﹤0.01%	3173
2024 Q1	$3.72K	Hold	400	–	–	﹤0.01%	3135
2023 Q4	$3.38K	Hold	400	–	–	﹤0.01%	3099
2023 Q3	$3.1K	Hold	400	–	–	﹤0.01%	2973
2023 Q2	$4.58K	Hold	400	–	–	﹤0.01%	2816
2023 Q1	$3.08K	Hold	400	–	–	﹤0.01%	2931
2022 Q4	$2.44K	Hold	400	–	–	﹤0.01%	2978
2022 Q3	$2K	Hold	400	–	–	﹤0.01%	3074
2022 Q2	$2K	Hold	400	–	–	﹤0.01%	3048
2022 Q1	$3K	Hold	400	–	–	﹤0.01%	3047
2021 Q4	$1K	Sell	400 -1,750	-81%	-$5.97K	﹤0.01%	3132
2021 Q3	$6K	Hold	2,150	–	–	﹤0.01%	2776
2021 Q2	$9K	Hold	2,150	–	–	﹤0.01%	6269
2021 Q1	$10.1K	Hold	2,150	–	–	﹤0.01%	2780
2020 Q4	$15K	Sell	2,150 -200	-9%	-$1.92K	﹤0.01%	2166
2020 Q3	$25K	Hold	2,350	–	–	﹤0.01%	1813
2020 Q2	$30K	Hold	2,350	–	–	﹤0.01%	1620
2020 Q1	$21K	Sell	2,350 -2,000	-46%	-$23K	﹤0.01%	1599
2019 Q4	$60K	Buy	4,350 +3,350	+335%	+$48.7K	﹤0.01%	1327
2019 Q3	$17K	Hold	1,000	–	–	﹤0.01%	1792
2019 Q2	$27K	Buy	+1,000	New	+$22.9K	﹤0.01%	1591
2018 Q4	–	Sell	-1,000	Closed	-$19K	–	2141
2018 Q3	$19K	Hold	1,000	–	–	﹤0.01%	1589
2018 Q2	$20K	Hold	1,000	–	–	﹤0.01%	1475
2018 Q1	$18K	Hold	1,000	–	–	﹤0.01%	1383
2017 Q4	$16K	Buy	+1,000	New	+$17.1K	﹤0.01%	1210

Other funds holding VYGR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Steward Partners Investment Advisory's VYGR Position: Q2 2026 in Review

Steward Partners Investment Advisory sold out of Voyager Therapeutics (VYGR) in Q2 2026, closing a stake of 400 shares — an estimated $1.54K sold.

Steward Partners Investment Advisory first reported a position in VYGR in Q4 2017 and held it in 32 quarters. The position peaked at $60K in Q4 2019. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

Steward Partners Investment Advisory reported no remaining Voyager Therapeutics position as of Q2 2026 after selling out during the quarter.
Steward Partners Investment Advisory sold 400 Voyager Therapeutics shares in Q2 2026, an estimated $1.54K.
Steward Partners Investment Advisory first reported a position in Voyager Therapeutics in Q4 2017 and held it in 32 quarters.
Steward Partners Investment Advisory's Voyager Therapeutics position peaked at $60K in Q4 2019.
136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.